Zimvie Inc (ZIMV) Stock Price, Quote & News

Company Profile

ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to support dental tooth replacement and restoration procedures worldwide. The company offers dental implant systems and biomaterials; digital dentistry solutions; restorative and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the BellaTek brand nam...

Industry: Medical Devices

Sector: Healthcare

Phone: 800 342 5454

Website: www.zimvie.com

Address:

4555 Riverside Drive, Palm Beach Gardens, United States

ZacksResearch Jun. 9 at 4:54 PM

$ZIMV's new launch in Japan — a game-changer for digital dentistry? 🚀 RealGUIDE Software Suite and Implant Concierge service are set to enhance clinical efficiency and improve patient outcomes, opening up key growth opportunities in Japan's dental market. Learn how this could impact ZIMV's future growth here 👉 https://www.zacks.com/commentary/2491048/zimvie-stock-gains-following-the-launch-of-realguide-software-suite?cid=sm-stocktwits-2-2491048-body&ADID=SYND_STOCKTWITS_TWEET_2_2491048_BODY

0 · Reply

ZacksResearch Jun. 9 at 3:35 PM

$ZIMV pops on new product launch — but is this the start of a bigger digital push? The RealGUIDE Software Suite and Implant Concierge just launched in Japan, aimed at enhancing digital dental workflows. See what's driving momentum here 👉 https://www.zacks.com/stock/news/2491048/zimvie-stock-gains-following-the-launch-of-realguide-software-suite?cid=sm-stocktwits-2-2491048-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2491048_TEASER

0 · Reply

DonCorleone77 Jun. 5 at 12:08 PM

$ZIMV ZimVie announces launch of RealGUIDE dental implant software suite in Japan ZimVie announced the launch of its RealGUIDE Software Suite and Implant Concierge service in Japan. The launch of RealGUIDE and Implant Concierge in Japan expands dentists' access to a unique digital dental implant ecosystem-from implant planning to placement-with vertically integrated, end-to-end solutions. The dental implant market opportunity in Japan is significant, and Japan is ZimVie's largest market in the APAC region. "We are proud to offer an innovative digital dentistry solution tailored to the needs of the Japanese market," said Taishi Kondo, General Manager, Japan. "These launches are a significant step forward in supporting our customers in delivering new practice efficiencies and high-quality implant care with confidence."

0 · Reply

macroaxis May. 10 at 1:42 PM

$ZIMV - Volatility alert: ZimVie options pin risk is increasing https://www.macroaxis.com/stock-options/ZIMV/ZimVie-Inc?utm_source=dlvr.it&utm_medium=stocktwits

0 · Reply

bullbearpro May. 8 at 8:12 PM

$ZIMV https://www.stocktwits.com/symbol/ZIMV/earningscall

0 · Reply

bullbearpro May. 8 at 8:07 PM

$ZIMV

0 · Reply

Kcsuccess May. 5 at 6:44 PM

$ZIMV Based entirely on technical analysis, this appears to be exiting out of a downtrend that began in 2023. If this holds here at support, on Tuesday or Wednesday, it should start a reversing and trending higher. Depending on earnings, this could almost double its value over the next 90 days. Short term, I'll be looking for an indication that the previous trend is ending and a positive trend is beginning.

0 · Reply

DonCorleone77 Apr. 21 at 12:21 PM

$ZIMV ZimVie announces launch of its Immediate Molar Implant system in US ZimVie announced the launch of its Immediate Molar Implant System in the United States. ZimVie is expanding its already clinically proven TSX and T3 PRO Implant systems with an immediate molar solution, simplifying challenging clinical scenarios for providers and shortening treatment times for patients requiring molar implants. "The launch of our Immediate Molar Dental Implant System marks a significant milestone in our commitment to advancing dental technology," said ZimVie CEO Vafa Jamali. "We have expanded the offering of our implant systems to address the unique challenges of molar tooth restoration and provide patients shorter and more cost-effective treatment while delivering a more predictable, lasting outcome."

0 · Reply

FinJay Apr. 10 at 4:33 AM

$ZIMV https://youtu.be/Ow4qEcDoYn0?si=_7nWT1x5J1OpQsTm

0 · Reply

JarvisFlow Apr. 9 at 1:04 PM

Needham has adjusted their stance on ZimVie ( $ZIMV ), setting the rating to Hold.

0 · Reply

ZimVie: Screening Cheap (Rating Upgrade)

Jun 5, 2025, 8:00 AM EDT - 20 days ago

ZimVie Announces Launch of RealGUIDE® Dental Implant Software Suite and Implant Concierge® Service in Japan

May 14, 2025, 4:05 PM EDT - 6 weeks ago

ZimVie to Participate in the Stifel 2025 Jaws & Paws Conference

May 11, 2025, 7:18 AM EDT - 6 weeks ago

ZimVie Inc. (ZIMV) Q1 2025 Earnings Call Transcript

May 8, 2025, 4:05 PM EDT - 6 weeks ago

ZimVie Reports First Quarter 2025 Financial Results

Apr 24, 2025, 4:05 PM EDT - 2 months ago

ZimVie to Report First Quarter 2025 Financial Results on May 8, 2025

Apr 21, 2025, 8:00 AM EDT - 2 months ago

ZimVie Pioneers the Future of Molar Restoration with New Immediate Molar Dental Implant System

Mar 25, 2025, 4:05 PM EDT - 3 months ago

ZimVie to Participate in the 24th Annual Needham Virtual Healthcare Conference

Mar 13, 2025, 4:15 PM EDT - 3 months ago

ZimVie Announces Upcoming Changes to Company's Board of Directors

Mar 13, 2025, 2:35 PM EDT - 3 months ago

Dental Players Dentsply Sirona, ZimVie Show Weak Growth Outlook: Analyst

XRAY

Feb 26, 2025, 7:52 PM EST - 4 months ago

ZimVie Inc. (ZIMV) Q4 2024 Earnings Call Transcript

Feb 26, 2025, 4:05 PM EST - 4 months ago

ZimVie Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 12, 2025, 4:05 PM EST - 4 months ago

ZimVie to Report Fourth Quarter and Full-Year 2024 Financial Results on February 26, 2025

Jan 30, 2025, 8:00 AM EST - 5 months ago

ZimVie Announces Publication of a Study Supporting the Benefits of Its Implant Surface Technologies

Oct 30, 2024, 7:58 PM EDT - 8 months ago

ZimVie Inc. (ZIMV) Q3 2024 Earnings Call Transcript

Oct 16, 2024, 4:05 PM EDT - 9 months ago

ZimVie to Report Third Quarter Financial Results on October 30, 2024

Aug 4, 2024, 10:53 AM EDT - 11 months ago

ZimVie Inc. (ZIMV) Q2 2024 Earnings Call Transcript

Jul 23, 2024, 8:00 AM EDT - 1 year ago

ZimVie Announces FDA Clearance and U.S. Launch of GenTek® Restorative Components

Jul 18, 2024, 4:05 PM EDT - 1 year ago

ZimVie to Report Second Quarter Financial Results on August 1, 2024

May 16, 2024, 4:05 PM EDT - 1 year ago

ZimVie to Participate in Upcoming Investor Conferences

May 11, 2024, 6:07 AM EDT - 1 year ago

ZimVie Inc. (ZIMV) Q1 2024 Earnings Call Transcript

Apr 24, 2024, 4:05 PM EDT - 1 year ago

ZimVie to Report First Quarter Financial Results on May 8, 2024

Apr 1, 2024, 8:00 AM EDT - 1 year ago

H.I.G. Capital Acquires the Spine Business of ZimVie Rebranded as Highridge Medical

Apr 1, 2024, 8:00 AM EDT - 1 year ago

ZimVie Announces Closing of Sale of Spine Business

Mar 27, 2024, 8:00 AM EDT - 1 year ago

ZimVie to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Feb 28, 2024, 9:52 PM EST - 1 year ago

ZimVie Inc. (ZIMV) Q4 2023 Earnings Call Transcript

Feb 21, 2024, 5:00 PM EST - 1 year ago

ZimVie to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024

Feb 7, 2024, 4:05 PM EST - 1 year ago

ZimVie Announces Launch of Next-Generation TSX® Implant in Japan

Dec 26, 2023, 7:21 PM EST - 1 year ago

ZimVie: Focusing On Higher Growth Dental Business (Rating Upgrade)

Nov 1, 2023, 9:57 PM EDT - 1 year ago

ZimVie Inc. (ZIMV) Q3 2023 Earnings Call Transcript

Oct 31, 2023, 8:00 AM EDT - 1 year ago

ZimVie Announces First U.S. Surgery with the 4.5mm Mobi-C® Cervical Disc

Oct 17, 2023, 8:30 AM EDT - 1 year ago

ZimVie Announces the Launch of Azure™ Multi-Platform Product Solutions

Oct 11, 2023, 4:05 PM EDT - 1 year ago

ZimVie to Report Third Quarter 2023 Financial Results on November 1, 2023

Oct 10, 2023, 8:30 AM EDT - 1 year ago

ZimVie Announces the Recent Launch of Biotivity™ A/C Plus Membrane

Sep 26, 2023, 8:00 AM EDT - 1 year ago

ZimVie Announces FDA Approval to Launch Mobi-C® Hybrid Study

Aug 17, 2023, 8:00 AM EDT - 2 years ago

ZimVie Expands Development Cooperation Agreement with Brainlab AG to Include Co-Marketing

Aug 6, 2023, 2:21 AM EDT - 2 years ago

ZimVie Inc. (ZIMV) Q2 2023 Earnings Call Transcript

Aug 2, 2023, 4:05 PM EDT - 2 years ago

ZimVie Reports Second Quarter 2023 Financial Results and Provides Update to Annual Guidance

Jul 12, 2023, 4:05 PM EDT - 2 years ago

ZimVie to Report Second Quarter 2023 Financial Results on August 2, 2023

Jun 21, 2023, 12:15 AM EDT - 2 years ago

ZimVie: Downgrade To A Hold On Valuation And Fundamentals

May 22, 2023, 4:05 PM EDT - 2 years ago

ZimVie to Present at the Stifel 2023 Jaws & Paws Conference

May 4, 2023, 11:51 AM EDT - 2 years ago

ZimVie Inc. (ZIMV) Q1 2023 Earnings Call Transcript

Apr 13, 2023, 8:30 AM EDT - 2 years ago

ZimVie Announces the Recent Launches of RegenerOss® CC Allograft Particulate and RegenerOss® Bone Graft Plug

Apr 12, 2023, 4:10 PM EDT - 2 years ago

ZimVie to Report First Quarter 2023 Financial Results on May 3, 2023

Apr 3, 2023, 9:00 AM EDT - 2 years ago

ZimVie Announces Expanded Reimbursement and Exemplary Clinical Rating for Mobi-C®

Mar 23, 2023, 8:30 AM EDT - 2 years ago

ZimVie's Exclusive Puros® Cancellous Particulate Allograft Dental Bone Grafting Solution Excels in Landmark Comparative Study in The International Journal of Oral & Maxillofacial Implants

Mar 15, 2023, 8:30 AM EDT - 2 years ago

ZimVie Announces Additional Positive Policy Decisions for Vertebral Body Tethering

Mar 1, 2023, 7:47 PM EST - 2 years ago

ZimVie Inc. (ZIMV) Q4 2022 Earnings Call Transcript

Mar 1, 2023, 4:05 PM EST - 2 years ago

ZimVie Reports Fourth Quarter and Full Year 2022 Financial Results

Feb 23, 2023, 8:30 AM EST - 2 years ago

ZimVie Announces Launch of the RealGUIDE™ CAD and FULL SUITE Software Modules

ZacksResearch Jun. 9 at 4:54 PM

0 · Reply

ZacksResearch Jun. 9 at 3:35 PM

0 · Reply

DonCorleone77 Jun. 5 at 12:08 PM

0 · Reply

macroaxis May. 10 at 1:42 PM

$ZIMV - Volatility alert: ZimVie options pin risk is increasing https://www.macroaxis.com/stock-options/ZIMV/ZimVie-Inc?utm_source=dlvr.it&utm_medium=stocktwits

0 · Reply

bullbearpro May. 8 at 8:12 PM

$ZIMV https://www.stocktwits.com/symbol/ZIMV/earningscall

0 · Reply

bullbearpro May. 8 at 8:07 PM

$ZIMV

0 · Reply

Kcsuccess May. 5 at 6:44 PM

0 · Reply

DonCorleone77 Apr. 21 at 12:21 PM

0 · Reply

FinJay Apr. 10 at 4:33 AM

$ZIMV https://youtu.be/Ow4qEcDoYn0?si=_7nWT1x5J1OpQsTm

0 · Reply

JarvisFlow Apr. 9 at 1:04 PM

Needham has adjusted their stance on ZimVie ( $ZIMV ), setting the rating to Hold.

0 · Reply

PenkeTrading Apr. 2 at 3:31 PM

I found you an Oversold RSI (Relative Strength Index) on the daily chart of ZimVie Inc. Is that bullish or bearish? $ZIMV #ZimVie #RsiOversold #NASDAQ

0 · Reply

jParkz Mar. 13 at 11:30 PM

News out $ZIMV ZimVie Announces Upcoming Changes to Company's Board of Directors https://marketwirenews.com/news-releases/zimvie-announces-upcoming-changes-to-xa0-company-s-b-7351874754046863.html $ZIMV

0 · Reply

JarvisFlow Mar. 13 at 11:30 AM

Needham has updated their rating for ZimVie ( $ZIMV ) to Hold.

0 · Reply

d_risk Feb. 27 at 4:28 PM

$ZIMV - ZimVie Inc. Common Stock - 10K - Updated Risk Factors ZIMV 2025 Risk Factors: New concerns over employee retention, patent protection, hazardous materials compliance, and stock price volatility could impact operations and investment value. #Risk https://d-risk.ai/ZIMV/10-K/2025-02-26

0 · Reply

JarvisFlow Feb. 27 at 12:42 PM

Needham has updated their rating for ZimVie ($ZIMV) to Buy with a price target of 23.

0 · Reply

DonCorleone77 Feb. 26 at 9:35 PM

$ZIMV ZimVie reports Q4 adjusted EPS 27c, consensus 26c Reports Q4 revenue $111.52M, consensus $113.66M. "2024 was a transformational year for ZimVie. We became a pure play dental company and reshaped our financial profile, reducing net debt by more than $290 million. We also streamlined our organization through corporate cost reduction, introduced manufacturing and supply chain efficiency initiatives, and increased Adjusted EBITDA margins by over 4 percentage points in the fourth quarter of 2024 compared to the fourth quarter of 2023 despite a softer end market," said Vafa Jamali, president and CEO. "We continue to be optimistic about the long-term drivers of the dental implant market, supported by the continued success of our training and education programs in 2024. I believe ZimVie is well positioned to take advantage of the growth in the dental implant and digital solutions market for 2025 and beyond."

0 · Reply

Theflash88 Jan. 28 at 8:23 PM

$ZIMV Ready for a BO!

0 · Reply

BackWatchonly Jan. 27 at 9:56 PM

$ZIMV Nice!

0 · Reply

NVDAMillionaire Dec. 12 at 11:18 AM

$ZIMV ZimVie Inc (ZIMV): Executing a Focused Growth Strategy in the Dental Market https://beyondspx.com/article/zimvie-inc-zimv-executing-a-focused-growth-strategy-in-the-dental-market

0 · Reply

DonCorleone77 Oct. 30 at 8:49 PM

$ZIMV ZimVie reports Q3 EPS 12c, consensus 7c Reports Q3 revenue $103.2M, consensus $101.4M...Adjusted EBITDA for the third quarter of 2024 was $13.1 million, or 12.7% of third party net sales, an increase of $0.9 million or 110 basis points versus the third quarter of 2023.."In the third quarter we saw an improvement to revenue growth in our largest market of North America, achieved manufacturing efficiencies, and saw increased adoption of our digital offerings," said Vafa Jamali, President and Chief Executive Officer. "In addition to our continued focus on driving operational improvement, we made incremental investments in our sales force, R&D initiatives and training programs designed to ensure ZimVie is well positioned for expansion into the future."

0 · Reply

PenkeTrading Oct. 26 at 4:07 PM

I found you an Oversold RSI (Relative Strength Index) on the daily chart of ZimVie Inc. Is that bullish or bearish? $ZIMV #ZimVie #RsiOversold #NASDAQ

0 · Reply

Dingusbro Oct. 10 at 5:18 PM

$ZIMV wheres the buy out?

0 · Reply

Market Cap	246.72M
Revenue (ttm)	449.75M
Net Income (ttm)	-25.83M
EPS (ttm)	N/A
PE Ratio	10.95
Forward PE	N/A
Profit Margin	-5.74%
Debt to Equity Ratio	0.56

Volume	116,100
Avg Vol	142,872
Day's Range	N/A - N/A
Shares Out	27.85M
Stochastic %K	55%
Beta	2.10
Analysts	Hold
Price Target	$11.67